Lodrane 24 Extended Release (brompheniramine maleate)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

Generic name: brompheniramine maleate

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Lodrane 24 Extended Release

Intelligence content is not available yet.

Indications

The following indications are listed for Lodrane 24 Extended Release:

  • Allergic Conjunctivitis
  • Allergic Rhinitis
  • Anaphylaxis Adjunct
  • Dermatographic Urticaria
  • Nasal Congestion
  • Pruritus Of Skin
  • Rhinorrhea
  • Sneezing
  • Urticaria
  • Vasomotor Rhinitis

Also known as: Adjunct Medication Therapy For Anaphylactic Reaction, Adjunct Medication Therapy For Anaphylaxis, Allergy Eye Itch, Atopic Conjunctivitis, Autographism, Cnidosis, Dermatography, Dermographia, Dermographism, Dermography, Ebbecke's Reaction, Factitious Urticaria, Itching Wheals, Itchy Eyes Due To Allergies, Itchy Skin Eruption, Nasal Stuffiness, Nettle Rash, Ocular Itching Due To Allergies, Pruritic Dermatitis, Skin Writing, Uredo, Urticaria Factitia, Urticarial Rash, Urtication, Weal.

Dosing

No dosing information is available for this tab.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data